Moderna, Inc. Contracts & Agreements

64 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Executive Retirement and Strategic Consulting Agreement by and between ModernaTX, Inc. and David Meline, dated as of April
Consulting Agreements
Moderna, Inc.
Biotechnology
MA
2022
2018 Employee Stock Purchase Plan, as amended
Stock Agreements
Moderna, Inc.
2024
Executive Separation
Separation Agreements
Moderna, Inc.
2024
2018 Employee Stock Purchase Plan
Stock Agreements
Moderna, Inc.
2024
Form of Employee Restricted Stock Unit Award Agreemen
Stock Agreements
Moderna, Inc.
2024
Form of Employee Non-Qualified Stock Option Agreement
Stock Agreements
Moderna, Inc.
2024
Amended and Restated Executive Severance Plan and Form of Participation Letter, as amended on February
Severance Agreements
Moderna, Inc.
Biotechnology
MA
2023
Offer Letter by and between ModernaTX, Inc. and Arpa Garay, dated as of April 21, 2022
Moderna, Inc.
Biotechnology
2023
Amended and Restated Non-Employee Director Compensation Policy, effective October 1, 2022
Compensation Agreements
Moderna, Inc.
Biotechnology
2022
Offer Letter by and between ModernaTX, Inc. and James Mock, dated as of August 15, 2022
Moderna, Inc.
Biotechnology
2022
Amendment No. PZ0025 and P00026 to Award Contract No. W911QY20C0100, by and between Moderna US Inc. and the Army Contracting Command of the U.S. Department of Defense, dated...
Moderna, Inc.
Biotechnology
2022
Amended and Restated Non-Employee Director Compensation Policy, effective April 28, 2022
Compensation Agreements
Moderna, Inc.
Biotechnology
2022
Amendment No. 13 to Agreement No. HHSO100201600029C, by and between ModernaTX, Inc. and the Biomedical Advanced Research and Development Authority, dated as of March 23, 2022
Development Agreements
Moderna, Inc.
2022
Amendment No. P00024 to Award Contract No. W911QY20C0100, by and between Moderna US Inc. and the Army Contracting Command of the U.S. Department of Defense, dated August 9, 2020
Moderna, Inc.
2022
Updated Executive Retirement and Strategic Consulting Agreement, dated May 27, 2022, between ModernaTX, Inc. and David Meline
Consulting Agreements
Moderna, Inc.
2022
Executive Separation Agreement and Release, dated May 13, 2022, between ModernaTX, Inc. and Jorge Gomez
Separation Agreements
Moderna, Inc.
2022
Offer Letter by and between ModernaTX, Inc. and Jorge Gomez, dated as of April 6, 2022
Moderna, Inc.
2022
Amendment No. 12 to Agreement No. HHSO100201600029C, by and between ModernaTX, Inc. and the Biomedical Advanced Research and Development Authority, dated as of March 23, 2022
Development Agreements
Moderna, Inc.
Biotechnology
2022
Amendment Nos. P00022 and P00023 to Award Contract No. W911QY20C0100, by and between Moderna US Inc. and the Army Contracting Command of the U.S. Department of Defense, dated...
Moderna, Inc.
2022
Third Amendment, dated September 11, 2018, Fourth Amendment, dated March 28, 2019, and Omnibus Amendment, dated December 30, 2021, to Net Lease, dated as of August 29, 2016, as...
Lease Agreements
Moderna, Inc.
Biotechnology
MA
2022
Offer Letter by and between ModernaTX, Inc. and Corin
Moderna, Inc.
Biotechnology
2022
Executive Separation and Transitional Services Agreement
Separation Agreements
Moderna, Inc.
2022
Consulting Agreement by and between ModernaTX, Inc. and Corinne Le Goff
Consulting Agreements
Moderna, Inc.
2022
Employment Letter Agreement between ModernaTX, Inc. and Shannon Klinger, dated as of March 4, 2021
Employment Agreements
Moderna, Inc.
2022
Form of Employee Restricted Stock Unit Award Agreement
Stock Agreements
Moderna, Inc.
Biotechnology
2022
Form of Employee Non-Qualified Stock Option Agreement
Stock Agreements
Moderna, Inc.
2022
Form of Non-Employee Director Restricted Stock Unit Award Agreement
Stock Agreements
Moderna, Inc.
2022
Form of Non-Employee Director Non-Qualified Stock Option Agreement
Stock Agreements
Moderna, Inc.
Biotechnology
2022
Amendment No. 11 to Agreement No. HHSO100201600029C, by and between ModernaTX, Inc. and the Biomedical Advanced Research and Development Authority, dated as of November 4, 2021
Development Agreements
Moderna, Inc.
2022
Amendment Nos. P00018, P00019, P00020, and P00021 to Award Contract No. W911QY20C0100, by and between Moderna US Inc. and the Army Contracting Command of the U.S. Department of...
Moderna, Inc.
2022
Amendment Nos. P00012, P00013, P00014, P00015, P00016 and P00017 to Award Contract No. W911QY20C0100, by and between Moderna US Inc. and the Army Contracting Command of the U.S....
Moderna, Inc.
2021
Amendment No
Moderna, Inc.
2021
Amendment No. 6, dated February 16, 2021
Moderna, Inc.
Biotechnology
2021
Amendment No. 7, dated March 12, 2021, to Agreement No. HHSO100201600029C, by and between ModernaTX, Inc. and the Biomedical Advanced Research and Development Authority, dated as...
Development Agreements
Moderna, Inc.
Biotechnology
2021
Form of Performance-Based Restricted Stock Unit Award Agreement under the 2018 Stock Option and Incentive Plan
Bonus & Incentive Agreements
Moderna, Inc.
2021
Amended and Restated Non-Employee Director Compensation Policy, effective April 28, 2021
Compensation Agreements
Moderna, Inc.
2021
Description of Capital Stock
Stock Agreements
Moderna, Inc.
2021
Amended and Restated Executive Retention Agreement by and between the Company and Tal Zaks, dated as of February 23, 2021
Retention Agreements
Moderna, Inc.
2021
Amendment No. P00003 to Award Contract No. W911QY20C0100, by and between Moderna US Inc. and the Army Contracting Command of the U.S. Department of Defense, dated December 11, 2020
Moderna, Inc.
Biotechnology
2021
Agreement No. HHSO100201600029C, by and between the Company and the Biomedical Advanced Research and Development Authority, dated as of April 16, 2020, as amended on May 24, 2020,...
Development Agreements
Moderna, Inc.
2020
Global Long Term Agreement, by and among ModernaTX Inc., Lonza Sales Ltd., and Lonza Ltd., dated September 4, 2020
Sales Agreements
Moderna, Inc.
Biotechnology
NY
2020
Award Contract No. W911QY20C0100, by and between Moderna US Inc. and the Army Contracting Command of the U.S. Department of Defense, dated August 9, 2020, as amended September 8,...
Moderna, Inc.
2020
Agreement No. HHSO100201600029C, by and between the Company and the Biomedical Advanced Research and Development Authority, dated as of April 16, 2020, as amended
Development Agreements
Moderna, Inc.
Biotechnology
2020
Offer Letter by and between the Company and David W. Meline, dated as of June 3, 2020
Moderna, Inc.
Biotechnology
2020
Underwriting Agreement, dated as of May 18, 2020, by and between Moderna, Inc. and Morgan Stanley & Co. LLC
Underwriting Agreements
Moderna, Inc.
2020
Executive Retention and Separation Agreement, dated May 5, 2020, by and between Moderna, Inc. and Lorence Kim, M.D
Retention Agreements
Moderna, Inc.
Biotechnology
MA
2020
Executive Retention Agreement, dated March 29, 2020, by and between Moderna, Inc. and Tal Zaks, M.D
Retention Agreements
Moderna, Inc.
2020
Description of Capital Stock
Stock Agreements
Moderna, Inc.
Biotechnology
2020
Offer Letter by and between the Company and Tal Zaks, dated as of February 17, 2015
Moderna, Inc.
2020
Offer Letter by and between the Company and Juan Andres, dated as of March 16, 2017
Moderna, Inc.
Biotechnology
2020
Underwriting Agreement, dated as of February 11, 2020, by and among Moderna, Inc. and Goldman Sachs & Co. LLC and Morgan Stanley & Co. LLC, as representatives of the underwriters
Underwriting Agreements
Moderna, Inc.
2020
Fifth Amendment to Lease, by and between ModernaTx, Inc. and ARE-Tech Square, LLC dated as of August 28, 2019
Lease Agreements
Moderna, Inc.
2019
Fifth Amendment to Collaboration and License Agreement by and between ModernaTX, Inc. and Merck Sharp & Dohme Corp., dated as of May 3, 2019
Collaboration Agreements
Moderna, Inc.
Biotechnology
2019
Amended and Restated Non-Employee Director Compensation Policy
Compensation Agreements
Moderna, Inc.
2019
Strategic Advisor & Transition Agreement by and between ModernaTX, Inc. and John Mendlein, dated as of January 17, 2019
Transition Agreements
Moderna, Inc.
2019
Form of Underwriting Agreement
Underwriting Agreements
Moderna, Inc.
Biotechnology
MA
2018
Form of Non-Plan Restricted Stock Award Agreement
Stock Agreements
Moderna, Inc.
Biotechnology
MA
2018
Form of Non-Plan Non-Qualified Stock Option Agreement
Stock Agreements
Moderna, Inc.
2018
Specimen Common Stock Certificate
Stock Agreements
Moderna, Inc.
2018
Second Amended and Restated Investors Rights Agreement by and among the Registrant and certain of its stockholders, dated May 7, 2018
Investor Rights Agreements
Moderna, Inc.
Biotechnology
MA
2018
2016 Stock Option and Grant Plan, as amended, and forms of award agreements thereunder
Stock Agreements
Moderna, Inc.
2018
2018 Stock Option and Incentive Plan and forms of award agreements thereunder
Bonus & Incentive Agreements
Moderna, Inc.
2018
Form of Indemnification Agreement between the Registrant and each of its directors
Indemnification Agreements
Moderna, Inc.
Biotechnology
DE
2018
Master Collaboration and License Agreement, by and between Moderna Therapeutics, Inc. and Merck Sharp & Dohme Corp., dated as of January 12, 2015, as amended by Amendment No. 1...
Collaboration Agreements
Moderna, Inc.
Biotechnology
NY
2018